Singapore-based biotech firm ArrowBiome raises US$1m in seed funding

The firm looks to tap the booming global market of skincare.

Singapore-based biotech firm ArrowBiome on Tuesday announced that it reached US$1m in its seed funding round from early-stage venture capital firm, Cocoon Capital.

Arrow Biome said the funds will be used for research and development and clinical validation that could help the company establish more commercial partnerships become a leader in microbiome management globally.

Particularly, the fresh capital will be used to support the development and commercialisation of its microbiome management solutions targeting specific bacterial strains.

Chong Goh, founder and CEO of ArrowBiome, said their initial focus is to provide solutions for skin-related applications like skincare products, and eventually develop solutions for gut microbiome and antimicrobial resistance.

The firm pointed to a huge market for its novel skincare solutions, with acne problems affecting 85% of teenagers and young adults worldwide and armpit odor a major issue for the majority of the global population.

Also Read

Singaporeans' physical well-being at highest level since 2019

SingHealth partners with OutcomesAI to integrate AI into medical workflows

Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

I want to download the media kit